Skip to content
Open access

Monitoring of quality of care for atrial fibrillation after guideline introduction in Cyprus

Oct 2026 · European Journal of Public Health · Vol 36 · 0 citations

TL;DR

Recommendation implementation in Cyprus improved screening and anticoagulation but revealed major gaps in patient safety monitoring and risk stratification, highlighting the need for stronger, system-level implementation.

Abstract

Abstract Issue Atrial fibrillation (AF) is a major contributor to morbidity and mortality in the elderly, and its effective management can reduce the associated health burden. However, real-world evidence shows persistent gaps in relevant guidelines’ implementation in Europe and elsewhere. In 2023, Cyprus contextualised the NICE NG196 AF guideline within its national health system and introduced measurable quality-of-care indicators. Description of the problem We evaluated guideline implementation through four indicators using national electronic health records across three periods: baseline (2022–2023) and two post-implementation years (2023–2025). Indicators captured key management domains: anticoagulation, screening, patient safety monitoring, and stroke risk stratification. Results The proportion of AF patients admitted for stroke on anticoagulation increased from 61.1% at baseline to 69.3% in year one (+8.2%, p = 0.086), with no further improvement in year two. More interestingly, pulse rhythm assessment in high-risk individuals improved markedly from 17.1% to 39.4% (+22.3%, p < 0.001) and further to 51.4% in year two (+12%, p < 0.001). In contrast, safety monitoring in anticoagulated patients was suboptimal at baseline and year one (67.8%) and declined to 58.6% in year two (−9.2%, p < 0.001), while stroke risk stratification using the CHA₂DS₂-VASc score was very limited, at 1.2% after implementation. Lessons Improvements were observed in anticoagulation and screening, but critical gaps remain in safety monitoring and risk stratification. Our findings highlight the need for stronger, system-level implementation, including decision support tools, incentives and integration of key practices into routine workflows. Key messages • Atrial Fibrillation guideline implementation in Cyprus improved screening and anticoagulation but revealed major gaps in patient safety monitoring and risk stratification. • System-level and indicator-based monitoring can strengthen quality of care and reduce cardiovascular burden.

Read PDF

Similar papers

Open access Sep 2026

Inequalities in oral anticoagulant treatment patterns: a two-part model to estimate healthcare costs associated with atrial fibrillation.

Failure to initiate, discontinuation and cessation of OAC treatment are linked to higher costs, highlighting the relevance of sustained anticoagulation, and improving treatment initiation and persistence could reduce the economic burden of AF and improve patient outcomes.

G. Ciminata, Ryan J. Mulholland, Terry J. Quinn et al. · 0 citations
Open access Sep 2026

Adherence to Anticoagulants in People with Stroke and Atrial Fibrillation: Implementation of Standardised Analytic Methods in Australia and Canada.

BACKGROUND Post-stroke medication adherence can be assessed using dispensing data; however, variations in methods hinder reliable comparisons across regions. AIM To develop and implement standardised methods to compare medication adherence to direct oral anticoagulants (DOACs) post-stroke between countries. METHODS...

L. Dalli, M. Kilkenny, Anna Chu et al. · 0 citations
Open access Sep 2026

Temporal trends of outcomes following first hospitalization due to atrial fibrillation- a population-based study.

BACKGROUND Atrial fibrillation (AF) represents a substantial cause of hospitalization and healthcare burden. This study aimed to examine temporal trends in outcomes following an initial hospitalization for AF. METHODS We analyzed electronic health records from Clalit Health Services, Israel's largest healthcare provi...

Y. Moshkovits, T. Lerman, A. Barsheshet et al. · 0 citations
Oct 2026

Improving long-term outcomes in atrial fibrillation: temporal decline in stroke and dementia risk among Danish patients – a nationwide registry-based study

Atrial fibrillation (AF) is the most common cardiac arrhythmia and a major public health challenge, particularly in ageing populations. Today, improved awareness and screening strategies, and advances in diagnostic technology have enhanced our ability to detect AF earlier and initiate appropriate treatment. This...

C. Middelfart, J. Toennesen, P. Rasmussen et al. · 0 citations
Oct 2026

Use of Anticoagulation Among Patients With Atrial Fibrillation or Atrial Flutter in the United States.

BACKGROUND Oral anticoagulation (OAC) remains underused in patients with atrial fibrillation or flutter at high risk of ischemic stroke. We aimed to characterize documented OAC prescribing at diagnosis and during 1-year follow-up and identify factors associated with baseline OAC prescribing. METHODS Using electronic...

P. Gouda, Josephine Harrington, K. Arps et al. · 0 citations
Open access Oct 2026

The RIBAT-AFRICA-AF Registry (Registry Initiative Across Borders for Atrial Fibrillation in Africa)

Atrial fibrillation (AF) is associated with substantial morbidity, mortality, and healthcare costs. In African countries, AF management relies on international guidelines largely derived from non-African populations, underscoring the need for region-specific data. To provide real-world African data on the...

Z. Raissuni, A. Mahdhaoui, A. Kane et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.